BioMarin Pharmaceutical
BMRN
#1782
Rank
NZ$19.76 B
Marketcap
NZ$102.80
Share price
4.26%
Change (1 day)
-18.75%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): NZ$1.16 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are NZ$3.09 Billion. In 2024 the company made an earning of NZ$0.91 Billion, an increase over its 2023 earnings that were of NZ$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$1.16 B27.57%
2024 NZ$0.91 B187.31%
2023 NZ$0.31 B26.07%
2022 NZ$0.25 B-298.51%
2021 -NZ$0.13 Billion78.04%
2020 -NZ$71.3 Million-55.36%
2019 -NZ$0.16 Billion-33.56%
2018 -NZ$0.25 Billion297.78%
2017 -NZ$60.44 Million-95.68%
2016 -NZ$1.4 Billion437.12%
2015 -NZ$0.27 Billion23.91%
2014 -NZ$0.22 Billion-29.25%
2013 -NZ$0.3 Billion49.23%
2012 -NZ$0.2 Billion171.11%
2011 -NZ$73.49 Million103.01%
2010 -NZ$36.2 Million-3903.54%
2009 NZ$0.95 M-98.31%
2008 NZ$56.3 M-189.7%
2007 -NZ$62.77 Million51.02%
2006 -NZ$41.57 Million-61.58%
2005 -NZ$0.11 Billion-56.59%
2004 -NZ$0.25 Billion95.13%
2003 -NZ$0.13 Billion12.09%
2002 -NZ$0.12 Billion73.19%
2001 -NZ$65.78 Million18.32%
2000 -NZ$55.6 Million19.65%
1999 -NZ$46.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
NZ$15.32 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.88 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-NZ$46.23 Million-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$8.39 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$0.48 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA